Product Description

Anti-HRSV Fusion Protein Reference Antibody (Felvizumab, RUO)

Sizes: 100ug, 1mg

Catalogue Numbers: VK421046-100, VK421046-1000

Lead times: 1-2 weeks, if manufacturer has product in stock

Manufacturer/Ship Location: China

Description: Felvizumab [HuRSV19VHFNS/VK, RSHZ19, RSV monoclonal antibody, SB209763] is a humanised monoclonal antibody (IgG1) prepared by the humanization of an F protein-specific murine MAb. In in vitro studies, palivizumab, another humanized Mab specific for the F protein of RSV, was 4 to 5-fold more potent than felvizumab in neutralising RSV (Scott, 1999).

Reactivity: HRSV-A

Host: Humanized

Applications: ELISA, Bioactivity: FACS, Functional assay

Alternate Names: SB209763, HuRSV19VHFNS/VK, RSHZ19monoclonalantibody, SB209763, 167747-20-8

Clonality: Monoclonal

Isotype: IgG1, kappa

Target: F, Fusion glycoprotein F0, Fusion glycoprotein F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1

Purification: Protein A/G purified from cell culture supernatant.

Purity: >95% purity as determined by SDS-PAGE.

Expression System: Mammalian Cells

Storage and Stability: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.

Storage Buffer: 0.01M PBS, pH 7.4.

Form: Liquid

Accession: P03420

Endotoxin Level: Please contact the lab for this information.

Research Use Only